Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine

Por Hirst, Alexander, Knight, Chris, Hirst, Matt, Dunlop, Will, Akehurst, Ron
Publicado no Eur J Health Econ (2015)

Choosing vs. allocating: discrete choice experiments and constant‐sum paired comparisons for the elicitation of societal preferences

Por Skedgel, Chris D., Wailoo, Allan J., Akehurst, Ron L.
Publicado no Health Expect (2013)

The Budget Impact of Biosimilar Infliximab (Remsima(®)) for the Treatment of Autoimmune Diseases in Five European Countries

Por Jha, Ashok, Upton, Alex, Dunlop, William C. N., Akehurst, Ron
Publicado no Adv Ther (2015)

Challenging current views on bile acid diarrhoea and malabsorption

Por Kurien, Matthew, Thurgar, Elizabeth, Davies, Ashley, Akehurst, Ron, Andreyev, Jervoise
Publicado no Frontline Gastroenterol (2018)

Benefits, Challenges and Potential Strategies of Open Source Health Economic Models

Por Dunlop, William C. N., Mason, Nicola, Kenworthy, James, Akehurst, Ron L.
Publicado no Pharmacoeconomics (2016)

Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis

Por Cooper, Katy L, Madan, Jason, Whyte, Sophie, Stevenson, Matt D, Akehurst, Ron L
Publicado em 2011

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms

Por Lee, Dawn, Wilson, Koo, Akehurst, Ron, Cowie, Martin R, Zannad, Faiez, Krum, Henry, van Veldhuisen, Dirk J, Vincent, John, Pitt, Bertram, McMurray, John J V
Publicado em 2014